Hepatocellular Carcinoma as a Chronic Disease: Managing Ongoing Surveillance, Multiple Treatments, Symptoms, and Quality of Life

Description

Explore hepatocellular carcinoma (HCC) through the lens of living with a chronic disease. From the time of HCC diagnosis, most patients are faced with undergoing lifelong surveillance with regular multiphasic imaging studies and, often, undergoing multiple rounds of treatment including different types of locoregional and systemic therapies. This exacts a substantial toll on quality of life, limits the ability to participate in work and family-related activities, and imposes great symptom, psychological, physical, and financial burdens. Speakers focus on the importance of patients preparing for the long-term trajectory of liver cancer and for physicians to support them in their journey. 

Presentations

8:00 AM - 8:15 AM
Nov 09 2025
San Diego, CA

Quality Measures in Hepatocellular Carcinoma Care

Sumeet K. Asrani, MD MSc, Presenter
Liver Cancer
Patient Program
8:15 AM - 8:30 AM
Nov 09 2025
San Diego, CA

Patient-Reported Outcomes in Hepatocellular Carcinoma: Physical, Psychosocial, and Financial Burdens and Quality of Life

Anjana Pillai, MD, FAASLD, Presenter
Liver Cancer
Patient Program
8:30 AM - 8:45 AM
Nov 09 2025
San Diego, CA

Patient Presentation

Kay W Anderson, RN (ret), Presenter
Liver Cancer
Patient Program
8:45 AM - 9:00 AM
Nov 09 2025
San Diego, CA

Patient Presentation

Kara Klink, MSW, Presenter
Liver Cancer
Patient Program

Objectives

  • Recognize HCC as a chronic disease with a long-term trajectory in many patients.
  • Review the experience of patients living with HCC including symptom, psychosocial, physical, and financial burdens.
  • Describe quality measures in HCC care, including patient-reported outcomes.